Overview

Angiology Corporation of America (ACA) was organized in 2004 by Mr. Richard M. Small and Alfred S. Callahan III, M.D. to formulate a comprehensive vascular disease early detection preventive health screening. ACA's proprietary program imparts knowledge to consumers regarding their risk for vascular disease and empowers them to take charge of their vascular health to lessen their risk for having a heart attack or stroke.

Service Focus

100% Focused on Healthcare
100% of Angioscreen's customers are in the healthcare industry
Health Assessments accounts for 100% of their focus
Reviews

There are no reviews for Angioscreen.


Be the first to leave a review

Details

Min. Project Size: Any